JD Supra

Skinny Facts May Limit Supreme Court’s Decision in ‘Skinny Label’ Generic Drug Approval Case

The Supreme Court on Jan. 16, 2026, agreed to decide a case about how generic companies can communicate to the market about their products, including whether their product promotion may infringe ...
JD Supra

Supreme Court to Address ‘Skinny Label’ Patent Disputes

Aydin Harston Ph.D., Anh-Thu Lam, Ph.D. On January 16, 2026, the U.S. Supreme Court agreed to hear Hikma Pharmaceuticals USA, Inc. v. Amarin Pharma, Inc., a patent dispute that could reshape the ...